433 related articles for article (PubMed ID: 28790184)
1. Adiponectin protects against development of metabolic disturbances in a PCOS mouse model.
Benrick A; Chanclón B; Micallef P; Wu Y; Hadi L; Shelton JM; Stener-Victorin E; Wernstedt Asterholm I
Proc Natl Acad Sci U S A; 2017 Aug; 114(34):E7187-E7196. PubMed ID: 28790184
[TBL] [Abstract][Full Text] [Related]
2. Reproductive and metabolic phenotype of a mouse model of PCOS.
van Houten EL; Kramer P; McLuskey A; Karels B; Themmen AP; Visser JA
Endocrinology; 2012 Jun; 153(6):2861-9. PubMed ID: 22334715
[TBL] [Abstract][Full Text] [Related]
3. Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model.
Cox MJ; Edwards MC; Rodriguez Paris V; Aflatounian A; Ledger WL; Gilchrist RB; Padmanabhan V; Handelsman DJ; Walters KA
Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32301482
[TBL] [Abstract][Full Text] [Related]
4. Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
Xiong T; Rodriguez Paris V; Edwards MC; Hu Y; Cochran BJ; Rye KA; Ledger WL; Padmanabhan V; Handelsman DJ; Gilchrist RB; Walters KA
Am J Physiol Endocrinol Metab; 2022 Aug; 323(2):E145-E158. PubMed ID: 35658542
[TBL] [Abstract][Full Text] [Related]
5. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS).
Brown RE; Wilkinson DA; Imran SA; Caraty A; Wilkinson M
Brain Res; 2012 Jul; 1467():1-9. PubMed ID: 22668987
[TBL] [Abstract][Full Text] [Related]
7. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
Caldwell AS; Eid S; Kay CR; Jimenez M; McMahon AC; Desai R; Allan CM; Smith JT; Handelsman DJ; Walters KA
Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of glucocorticoids in 5α-dihydrotestosterone-induced PCOS-like metabolic disturbances in the rat visceral adipose tissue.
Nikolić M; Macut D; Djordjevic A; Veličković N; Nestorović N; Bursać B; Antić IB; Macut JB; Matić G; Vojnović Milutinović D
Mol Cell Endocrinol; 2015 Jan; 399():22-31. PubMed ID: 25179821
[TBL] [Abstract][Full Text] [Related]
9. Maternal adiponectin prevents visceral adiposity and adipocyte hypertrophy in prenatal androgenized female mice.
Wu Y; Chanclón B; Micallef P; Stener-Victorin E; Wernstedt Asterholm I; Benrick A
FASEB J; 2021 Apr; 35(4):e21299. PubMed ID: 33715227
[TBL] [Abstract][Full Text] [Related]
10. Differential Strain-dependent Ovarian and Metabolic Responses in a Mouse Model of PCOS.
Binder AK; Peecher DL; Qvigstad AJ; Gutierrez SD; Magaña J; Banks DB; Korach KS
Endocrinology; 2023 Feb; 164(4):. PubMed ID: 36718579
[TBL] [Abstract][Full Text] [Related]
11. Traditional Chinese Medicine formula FTZ protects against polycystic ovary syndrome through modulating adiponectin-mediated fat-ovary crosstalk in mice.
Xu Y; Tang J; Guo Q; Xu Y; Yan K; Wu L; Xie K; Zhu A; Rong X; Ye D; Guo J
J Ethnopharmacol; 2021 Mar; 268():113587. PubMed ID: 33212180
[TBL] [Abstract][Full Text] [Related]
12. Neuronal Ptpn1 and Socs3 deletion improves metabolism but not anovulation in a mouse polycystic ovary syndrome model.
Kerbus RI; Inglis MA; Anderson GM
J Endocrinol; 2023 Sep; 259(1):. PubMed ID: 37466473
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
14. Acupuncture does not ameliorate metabolic disturbances in the P450 aromatase inhibitor-induced rat model of polycystic ovary syndrome.
Maliqueo M; Benrick A; Marcondes RR; Johansson J; Sun M; Stener-Victorin E
Exp Physiol; 2017 Jan; 102(1):113-127. PubMed ID: 27790765
[TBL] [Abstract][Full Text] [Related]
15. Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome.
Mannerås L; Jonsdottir IH; Holmäng A; Lönn M; Stener-Victorin E
Endocrinology; 2008 Jul; 149(7):3559-68. PubMed ID: 18388196
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome.
Tan BK; Chen J; Digby JE; Keay SD; Kennedy CR; Randeva HS
Diabetologia; 2006 Nov; 49(11):2723-8. PubMed ID: 17001470
[TBL] [Abstract][Full Text] [Related]
17. Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
Münzker J; Hofer D; Trummer C; Ulbing M; Harger A; Pieber T; Owen L; Keevil B; Brabant G; Lerchbaum E; Obermayer-Pietsch B
J Clin Endocrinol Metab; 2015 Feb; 100(2):653-60. PubMed ID: 25387259
[TBL] [Abstract][Full Text] [Related]
18. Prenatal androgen excess programs metabolic derangements in pubertal female rats.
Yan X; Dai X; Wang J; Zhao N; Cui Y; Liu J
J Endocrinol; 2013 Apr; 217(1):119-29. PubMed ID: 23426873
[TBL] [Abstract][Full Text] [Related]
19. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
[No Abstract] [Full Text] [Related]
20. CMKLR1 deficiency maintains ovarian steroid production in mice treated chronically with dihydrotestosterone.
Tang M; Huang C; Wang YF; Ren PG; Chen L; Xiao TX; Wang BB; Pan YF; Tsang BK; Zabel BA; Ma BH; Zhao HY; Zhang JV
Sci Rep; 2016 Feb; 6():21328. PubMed ID: 26893072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
